This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXMPEA6K0UO_M.jpg
AbbVie announced earnings per share of $2.83 on revenue of $12.88B. Analysts polled by Investing.com anticipated EPS of $2.76 on revenue of $12.71B.
AbbVie shares are down 8% from the beginning of the year, still down 20.35% from its 52 week high of $101.28 set on July 17. They are under-performing the S&P 500 which is up 2.46% from the start of the year.
AbbVie shares gained 0.35% in pre-market trade following the report.
AbbVie’s report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
